TORONTO, July 02, 2019 (GLOBE NEWSWIRE) — Deveron UAS Corp. (CSE: DVR) (“Deveron” or the “Company”) is pleased to provide a corporate update on its operations as it continues to build an agriculture technology offering focused on optimizing yield and improving outcomes on the farm using field and crop data.
TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceuticals Inc. (“Prismic”), a US-based specialty R&D pharmaceutical company (the “Parties”), announced today that, on June 28, 2019, they finalized the acquisition by FSD Pharma of all of the issued and outstanding securities of Prismic (the “Transaction”). Pursuant to the terms of a previously-announced securities exchange Agreement, FSD Pharma has acquired all outstanding common and preferred shares of Prismic for an aggregate purchase price of approximately US$17.5 million (CAD$23.4 million based on an exchange rate of US$1 to CAD$1.3349), satisfied by the issuance of approximately 102.7 million Class B subordinate voting shares in the capital of FSD Pharma (each, an “FSD Share”) at
Continue Reading “FSD Pharma Closes Deal to Acquire Prismic Pharmaceuticals”
